Literature DB >> 26883257

Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: yes.

Thomas Bein1, Josef Briegel2, Djillali Annane3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26883257     DOI： 10.1007/s00134-015-4162-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

Review 1.  Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.

Authors:  G Umberto Meduri; Lisa Bridges; Mei-Chiung Shih; Paul E Marik; Reed A C Siemieniuk; Mehmet Kocak
Journal:  Intensive Care Med       Date:  2015-10-27       Impact factor: 17.440

2.  Use of Type III procollagen measurement as predictor of lung fibroproliferation in ARDS: early measurement for earlier antifibroproliferative therapy?

Authors:  Rémi Coudroy; Angéline Jamet; Oscar Peñuelas; Arnaud W Thille
Journal:  Intensive Care Med       Date:  2015-04-14       Impact factor: 17.440

3.  Mortality is the only relevant outcome in ARDS: no.

Authors:  John P Kress
Journal:  Intensive Care Med       Date:  2014-12-05       Impact factor: 17.440

4.  High-dose corticosteroids in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; J M Luce; C L Sprung; J E Rinaldo; R M Tate; W J Sibbald; K Kariman; S Higgins; R Bradley; C A Metz
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

5.  Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.

Authors:  G Umberto Meduri; Elizabeth A Tolley; George P Chrousos; Frankie Stentz
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

6.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material.

Authors:  Niall D Ferguson; Eddy Fan; Luigi Camporota; Massimo Antonelli; Antonio Anzueto; Richard Beale; Laurent Brochard; Roy Brower; Andrés Esteban; Luciano Gattinoni; Andrew Rhodes; Arthur S Slutsky; Jean-Louis Vincent; Gordon D Rubenfeld; B Taylor Thompson; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2012-08-25       Impact factor: 17.440

7.  Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.

Authors:  Catherine L Hough; Kenneth P Steinberg; B Taylor Thompson; Gordon D Rubenfeld; Leonard D Hudson
Journal:  Intensive Care Med       Date:  2008-10-23       Impact factor: 17.440

8.  Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids.

Authors:  G Umberto Meduri; Muthiah P Muthiah; Pierluigi Carratu; Mahmoud Eltorky; George P Chrousos
Journal:  Neuroimmunomodulation       Date:  2005       Impact factor: 2.492

Review 9.  Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy.

Authors:  G Umberto Meduri; Djillali Annane; George P Chrousos; Paul E Marik; Scott E Sinclair
Journal:  Chest       Date:  2009-10-03       Impact factor: 9.410

10.  Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial.

Authors:  G Umberto Meduri; Emmel Golden; Amado X Freire; Edwin Taylor; Muhammad Zaman; Stephanie J Carson; Mary Gibson; Reba Umberger
Journal:  Chest       Date:  2007-04       Impact factor: 9.410
View more
  5 in total

Review 1.  Beyond Low Tidal Volume Ventilation: Treatment Adjuncts for Severe Respiratory Failure in Acute Respiratory Distress Syndrome.

Authors:  Vikram Fielding-Singh; Michael A Matthay; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2018-11       Impact factor: 7.598

2.  Effective and Safe Use of Glucocorticosteroids for Rescue of Late ARDS.

Authors:  Paolo Diana; Dustin T Money; Michael G Gelvin; Nadia Lunardi
Journal:  Case Rep Crit Care       Date:  2017-02-26

3.  Nur77 attenuates endothelin-1 expression via downregulation of NF-κB and p38 MAPK in A549 cells and in an ARDS rat model.

Authors:  Yujie Jiang; Yi Zeng; Xia Huang; Yueqiu Qin; Weigui Luo; Shulin Xiang; Suren R Sooranna; Liao Pinhu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-07       Impact factor: 5.464

4.  Dexamethasone fails to improve bleomycin-induced acute lung injury in mice.

Authors:  Mélissa Aubin Vega; Cécile Chupin; Mihai Pascariu; Anik Privé; André Dagenais; Yves Berthiaume; Emmanuelle Brochiero
Journal:  Physiol Rep       Date:  2019-11

Review 5.  The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia.

Authors:  Thomas Bein; Salvatore Grasso; Onnen Moerer; Michael Quintel; Claude Guerin; Maria Deja; Anita Brondani; Sangeeta Mehta
Journal:  Intensive Care Med       Date:  2016-04-04       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.